Investors & VC Firms in Belgium

185 firms in this list, with a median first check of $550K. 44 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
FA Faraday Venture Partners GTÍSJBOC9 people	88🔒	—	ES	Pre-Seed–Series A	$330K – $1.1M	+ Add to CRM
DE Debiopharm Innovation Fund MCTMCTDS18 people · Leads rounds	88🔒	Lausanne	CH	Pre-Seed–Late Stage	$1M – $5M	+ Add to CRM
IN Intuitae CALGAAM26 people	88🔒	Paris	FR	—	—	+ Add to CRM
CO Cottonwood Technology Fund LRALAACC10 people · Leads rounds	88🔒	Denver	US	Pre-Seed–Growth	$1M – $25M	+ Add to CRM
WA Waterland CBFBJCPB20 people	88🔒	Bussum	NL	Growth	—	+ Add to CRM
NE NextGen Ventures EVMBPHRD18 people	88🔒	Ede	NL	Seed–Series A	—	+ Add to CRM
SE Senovo ABFMMGMG7 people	88🔒	Munich	DE	Seed–Late Stage	$1.1M – $5.4M	+ Add to CRM
IN Invivo Capital Partners AFLRLPTL11 people	88🔒	Barcelona	ES	Pre-Seed–Series A	$2.2M – $4.3M	+ Add to CRM
CO Colesco Capital Collective DVAWJRBO22 people	88🔒	Utrecht	NL	Growth	—	+ Add to CRM
GE German Media Pool AKNINWDA8 people · Follows rounds	88🔒	Berlin	DE	Seed–Late Stage	$550K – $5.5M	+ Add to CRM
TE TechVision Fund BKBLDAPB17 people · Leads rounds	88🔒	Aachen	DE	Pre-Seed–Series A	$550K – $2.2M	+ Add to CRM
EI EIT Digital Accelerator ASMEDDJM5 people	88🔒	Espoo	FI	Series A–Growth	$5M – $25M	+ Add to CRM
PA PAI Partners AAKBAAWP13 people	88🔒	Paris	FR	Growth–Late Stage	$108M – $324M	+ Add to CRM
AF AFI Ventures CFCDSL3 people	88🔒	Paris	FR	Pre-Seed–Series A	$108K – $550K	+ Add to CRM
TI Tioga Capital Partners NPRJIL11 people	88🔒	London	GB	Pre-Seed–Series B	$540K – $5M	+ Add to CRM
NE New Rhein Healthcare Investors, LLC NGIGSSAA15 people	88🔒	Philadelphia	US	Series A–Late Stage	—	+ Add to CRM
RT RTW Investments L.P. GMJMJKLC14 people	88🔒	New York	US	Seed–Series A	—	+ Add to CRM
FI Finch Capital Leads rounds	88🔒	Amsterdam	NL	Series A–Growth	$5.4M – $16.2M	+ Add to CRM
UN United Founders RVVHCPDJ17 people	88🔒	Senningerberg	LU	—	—	+ Add to CRM
CA Capital Mills BDEVGDRD6 people	88🔒	Gorinchem	NL	Series A–Late Stage	$270K – $2.7M	+ Add to CRM
VO Volve Capital JBMHBVHJ10 people · Leads rounds	88🔒	Amsterdam	NL	Pre-Seed–Seed	$215K – $540K	+ Add to CRM
SW Swisscom Ventures AS1 person · Leads rounds	88🔒	Zurich	CH	Pre-Seed–Growth	$2M – $10M	+ Add to CRM
VE Verto ADTFAKLD9 people · Leads rounds	88🔒	Paris	FR	Growth	$16.2M – $64.8M	+ Add to CRM
AD AdBio partners AHCBGD3 people	88🔒	Paris	FR	Pre-Seed–Series A	—	+ Add to CRM

Faraday Venture Partners

Pre-Seed–Series A$330K – $1.1M

GTÍSJBOC9 people

Debiopharm Innovation Fund

LausannePre-Seed–Late Stage$1M – $5M

MCTMCTDS18 people

Intuitae

Paris

CALGAAM26 people

Cottonwood Technology Fund

DenverPre-Seed–Growth$1M – $25M

LRALAACC10 people

Waterland

BussumGrowth

CBFBJCPB20 people

NextGen Ventures

EdeSeed–Series A

EVMBPHRD18 people

Senovo

MunichSeed–Late Stage$1.1M – $5.4M

ABFMMGMG7 people

Invivo Capital Partners

BarcelonaPre-Seed–Series A$2.2M – $4.3M

AFLRLPTL11 people

Colesco Capital Collective

UtrechtGrowth

DVAWJRBO22 people

German Media Pool

BerlinSeed–Late Stage$550K – $5.5M

AKNINWDA8 people

TechVision Fund

AachenPre-Seed–Series A$550K – $2.2M

BKBLDAPB17 people

EIT Digital Accelerator

EspooSeries A–Growth$5M – $25M

ASMEDDJM5 people

PAI Partners

ParisGrowth–Late Stage$108M – $324M

AAKBAAWP13 people

AFI Ventures

ParisPre-Seed–Series A$108K – $550K

CFCDSL3 people

Tioga Capital Partners

LondonPre-Seed–Series B$540K – $5M

NPRJIL11 people

New Rhein Healthcare Investors, LLC

PhiladelphiaSeries A–Late Stage

NGIGSSAA15 people

RTW Investments L.P.

New YorkSeed–Series A

GMJMJKLC14 people

Finch Capital

AmsterdamSeries A–Growth$5.4M – $16.2M

United Founders

Senningerberg

RVVHCPDJ17 people

Capital Mills

GorinchemSeries A–Late Stage$270K – $2.7M

BDEVGDRD6 people

Volve Capital

AmsterdamPre-Seed–Seed$215K – $540K

JBMHBVHJ10 people

Swisscom Ventures

ZurichPre-Seed–Growth$2M – $10M

AS1 person

Verto

ParisGrowth$16.2M – $64.8M

ADTFAKLD9 people

AdBio partners

ParisPre-Seed–Series A

AHCBGD3 people

Data sourced from public filings and firms' own websites — see our methodology.